Patisiran
id:
patisiran-262-15640303
title:
Patisiran
text:
Patisiran, sold under the brand name Onpattro, is a medication used for the treatment of polyneuropathy in people with hereditary transthyretin-mediated amyloidosis, a fatal rare disease that is estimated to affect 50,000 people worldwide. It is the first small interfering RNA-based drug approved by the U.S. Food and Drug Administration (FDA) and the first drug approved by the FDA to treat this condition. It is a gene silencing drug that interferes with the production of an abnormal form of tran
brand slug:
wiki
category slug:
encyclopedia
description:
Pharmaceutical drug
original url:
https://en.wikipedia.org/wiki/Patisiran
date created:
date modified:
2024-03-10T06:33:16Z
main entity:
{"identifier":"Q40441442","url":"https://www.wikidata.org/entity/Q40441442"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/5/58/Patisiran_sodium.svg","width":512,"height":173}
fields total:
13
integrity:
15